Suppr超能文献

病毒编码的 miR-155 同源物是一种重要的潜在调节剂,但对于非常强毒力马立克氏病病毒诱导的淋巴瘤的发展不是必需的。

Virus-encoded miR-155 ortholog is an important potential regulator but not essential for the development of lymphomas induced by very virulent Marek's disease virus.

机构信息

Key Laboratory of Animal Immunology of the Ministry of Agriculture, Henan Provincial Key Laboratory of Animal Immunology, Henan Academy of Agricultural Sciences, No.116 Huayuan Road, Zhengzhou 450002, People's Republic of China; College of Animal Science and Veterinary Medicine, Jilin University, Changchun 130062, People's Republic of China; College of Animal Science and Technology, Henan University of Science and Technology, Luoyang 471003, People's Republic of China.

出版信息

Virology. 2014 Jan 5;448:55-64. doi: 10.1016/j.virol.2013.09.017. Epub 2013 Oct 20.

Abstract

The microRNA (miRNA) mdv1-miR-M4, a functional miR-155 ortholog encoded by oncogenic Marek's disease virus (MDV), has previously been suggested to be involved in MDV pathogenesis. Using the technique of bacterial artificial chromosome mutagenesis, we have presently evaluated the potential role of mdv1-miR-M4 in the oncogenesis of the very virulent (vv) MDV strain GX0101. Unexpectedly, deletions of the Meq-cluster or mdv1-miR-M4 alone from the viral genome strongly decreased rather than abolished its oncogenicity. Compared to GX0101, mortalities of mutants GXΔmiR-M4 and GXΔMeq-miRs were reduced from 100% to 18% and 4%, coupled with the gross tumor incidence reduction from 28% to 22% and 8%, respectively. Our data suggests that the mdv1-miR-M4 is possibly an important regulator in the development of Marek's disease (MD) lymphomas but is not essential for the oncogenicity of vvMDV. In addition, some of the other Meq-clustered miRNAs may also play potentially critical roles in vvMDV induction of lymphomas.

摘要

微小 RNA(miRNA)mdv1-miR-M4 是一种由致瘤性马立克氏病病毒(MDV)编码的功能性 miR-155 同源物,先前被认为参与 MDV 发病机制。使用细菌人工染色体诱变技术,我们目前评估了 mdv1-miR-M4 在非常致瘤性(vv)MDV 株 GX0101 致癌中的潜在作用。出乎意料的是,Meq 簇或 mdv1-miR-M4 的缺失单独从病毒基因组中强烈降低而不是消除了其致瘤性。与 GX0101 相比,突变体 GXΔmiR-M4 和 GXΔMeq-miRs 的死亡率从 100%降低到 18%和 4%,同时总肿瘤发生率从 28%降低到 22%和 8%。我们的数据表明,mdv1-miR-M4 可能是马立克氏病(MD)淋巴瘤发展的重要调节剂,但不是 vvMDV 致瘤性所必需的。此外,Meq 簇中的一些其他 miRNA 也可能在 vvMDV 诱导淋巴瘤中发挥潜在的关键作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验